- Home
- GIBOW vs VRNA Comparison
GIBOW vs VRNA Comparison
Compare GIBOW & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIBOW
- VRNA
- Stock Information
- Founded
- GIBOW N/A
- VRNA 2005
- Country
- GIBOW Hong Kong
- VRNA United Kingdom
- Employees
- GIBOW N/A
- VRNA N/A
- Industry
- GIBOW Computer Software: Prepackaged Software
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- GIBOW Technology
- VRNA Health Care
- Exchange
- GIBOW Nasdaq
- VRNA Nasdaq
- Market Cap
- GIBOW N/A
- VRNA 8.3B
- IPO Year
- GIBOW N/A
- VRNA 2017
- Fundamental
- Price
- GIBOW $0.03
- VRNA $94.58
- Analyst Decision
- GIBOW
- VRNA Strong Buy
- Analyst Count
- GIBOW 0
- VRNA 8
- Target Price
- GIBOW N/A
- VRNA $105.38
- AVG Volume (30 Days)
- GIBOW N/A
- VRNA 1.2M
- Earning Date
- GIBOW N/A
- VRNA 08-07-2025
- Dividend Yield
- GIBOW N/A
- VRNA N/A
- EPS Growth
- GIBOW N/A
- VRNA N/A
- EPS
- GIBOW N/A
- VRNA N/A
- Revenue
- GIBOW N/A
- VRNA $118,535,000.00
- Revenue This Year
- GIBOW N/A
- VRNA $891.79
- Revenue Next Year
- GIBOW N/A
- VRNA $78.94
- P/E Ratio
- GIBOW N/A
- VRNA N/A
- Revenue Growth
- GIBOW N/A
- VRNA N/A
- 52 Week Low
- GIBOW N/A
- VRNA $14.15
- 52 Week High
- GIBOW N/A
- VRNA $99.01
- Technical
- Relative Strength Index (RSI)
- GIBOW N/A
- VRNA 68.57
- Support Level
- GIBOW N/A
- VRNA $92.88
- Resistance Level
- GIBOW N/A
- VRNA $99.01
- Average True Range (ATR)
- GIBOW 0.00
- VRNA 3.09
- MACD
- GIBOW 0.00
- VRNA -0.40
- Stochastic Oscillator
- GIBOW 0.00
- VRNA 69.04
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.